USPTO serial 97102407
GENERATE LIFE SCIENCES
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- GALBO, AMANDA
- Law office
- TMO LAW OFFICE 125
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with GENERATE LIFE SCIENCES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Los Angeles, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gregory N. Owen
Gregory N. Owen Owen, Wickersham & Erickson, P.C.2300 Clayton Road, Suite 1400One Concord CenterConcord, CA 94520Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software and mobile application for the delivery of test content and interpretations for clinical testing, and for the exchange of genetic information and genetic test results | ACTIVE | — |
| 035 | Wholesale distributorships featuring medical equipment; retail store services and online retail store services featuring medical equipment | ACTIVE | Dec 31, 2020 |
| 039 | Biomedical services, namely, storage of human blood, human umbilical cord blood, human umbilical cord blood stem cells, human umbilical cord tissue | ACTIVE | Dec 31, 2020 |
| 042 | Software as a service (SaaS) services featuring software for completing donor and recipient applications for fertility services, namely, in-vitro fertilization services, surrogacy services, embryo adoption services, sperm donations and human embryo donations; medical and scientific research and development in the field of pharmaceuticals, infectious diseases, genetics, genomics, fertility, biologic testing and interpretation, cellular therapies, immune diseases, ancestry analysis; providing temporary use of a web based software platform for storing, accessing, evaluating, and analyzing patients' bio-specimens, genetic information, and genetic test results; genetic testing for scientific research purposes; providing electronic genetic data storage and providing analysis in the field of genetic testing for scientific research and clinical research purposes for the health care industry; providing temporary use of a web based software platform for bioinformatics analysis for medical and diagnostic purposes; scientific analysis services, namely, DNA and medical record analysis services for scientific research and clinical research purposes for the health care industry; providing temporary use of a web-based software platform for the delivery of test content and interpretations for clinical testing, and for the exchange of genetic information and genetic test results | ACTIVE | Dec 31, 2020 |
| 044 | Collection and preservation of human placenta and placental tissue for scientific research and medical purposes in the fields of pharmaceuticals, infectious diseases, genetics, genomics, fertility, biologic testing and interpretation, cellular therapies, immune diseases; sperm and embryo bank services; reproductive tissue donation services; providing information for reproductive tissue donors and recipients via a website; medical services, namely, collection, testing, processing and preservation of human blood, human blood components, human tissue and umbilical cord tissue perivascular stem cells; cord blood bank services; providing information about cord blood and cord tissue banking via a website; medical testing services, namely, genetic testing services, DNA analysis and profiling, testing of reproductive tissue for medical and diagnostic purposes; medical testing services, namely, genetic testing services related to carrier screening, DNA extraction, polygenic risk assessment, pharmacogenomic testing, cardio risk assessment, stem cells, DNA analysis and profiling; clinical services, namely, genetic counseling | ACTIVE | Dec 31, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Generate IP Holdings LLC
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 039
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named GENERATE LIFE SCIENCES
- Prosecution event GNRN explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 8, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 8, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 8, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 24, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Aug 8, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 9, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 11, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 13, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 12, 2024 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Aug 4, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Apr 20, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 20, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 20, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 20, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 20, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 4, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 4, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 4, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 3, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 3, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 3, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 5, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 29, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 12, 2021 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Nov 11, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 4, 2021 | NWAP | NEW APPLICATION ENTERED | — |